The early interferon catches the SARS-CoV-2.

Thomas Decker1

  • 1Max Perutz Labs, University of Vienna, Vienna Biocenter, Vienna, Austria.

Summary

Sufficient antiviral interferon in the nasopharyngeal mucosa prevents SARS-CoV-2 replication in epithelial cells. Interferon-stimulated genes in the nasal lining can serve as infection biomarkers.